Announcement of Resolutions of the Tenth Meeting of the Fourth Board of Directors
Securities Code: 300653
Securities Abbreviation: Zhenghai Biological
Announcement Number: 2026-007
Yantai Zhenghai Biological Technology Co., Ltd. (hereinafter referred to as "the Company") held the Tenth Meeting of the Fourth Board of Directors on March 29, 2026, in person. The meeting notice was sent to all directors via email on March 19, 2026. A total of 9 directors were required to attend, and all 9 directors attended the meeting, with 9 present in person. The attendees included Mr. Guo Huanxiang, Ms. Xu Yueli, Mr. Zhang Chao, Mr. Song Kan, Ms. Zhao Li, Mr. Zhang Donggang, Mr. Song Xiliang, Mr. Wang Hui, and Mr. Li Jianghua. The meeting was chaired by Mr. Guo Huanxiang. The number of attendees, the manner of convening, and the voting method complied with the relevant provisions of the Company Law and the Articles of Association, making it legal and valid.
Meeting Resolutions
After discussion among the attending directors, the following resolutions were passed:
-
Proposal on the 2025 Annual Work Report of the Board of Directors
The "2025 Annual Work Report of the Board of Directors" accurately reflects the progress and achievements of the Board's work. The Board has diligently fulfilled its responsibilities assigned by the shareholders' meeting, operated in a standardized manner, made scientific decisions, and actively promoted the development of the Company's various businesses. The voting results were: 9 votes in favor, 0 votes against, 0 abstentions, and 0 avoidance votes. The proposal was approved with 100% of the votes from attending directors. This proposal will be submitted to the Company's 2025 Annual Shareholders' Meeting for review. The specific content can be found on the information disclosure website designated by the China Securities Regulatory Commission. -
Proposal on the 2025 Annual Work Report of the General Manager
The General Manager submitted and reported the "2025 Annual Work Report of the General Manager" to all directors. After review, the Board believes that the report objectively and truthfully reflects the work and achievements of the General Manager and management in implementing the resolutions of the Board and shareholders' meeting, as well as the production and operation situation. The voting results were: 9 votes in favor, 0 votes against, 0 abstentions, and 0 avoidance votes. The proposal was approved with 100% of the votes from attending directors. -
Proposal on the Full Text and Summary of the 2025 Annual Report
The preparation procedures for the Company's "2025 Annual Report Full Text" and "2025 Annual Report Summary" comply with the relevant laws, administrative regulations, and normative documents of the China Securities Regulatory Commission and Shenzhen Stock Exchange. The report content truthfully, accurately, and completely reflects the Company's actual situation, with no false records, misleading statements, or significant omissions. The voting results were: 9 votes in favor, 0 votes against, 0 abstentions, and 0 avoidance votes. The proposal was approved with 100% of the votes from attending directors. This proposal will be submitted to the Company's 2025 Annual Shareholders' Meeting for review. -
Proposal on the 2025 Annual Report of Independent Directors
The independent directors submitted the "2025 Annual Report of Independent Directors" to the Board, which accurately reflects their positive contributions in decision-making, supervision, and professional consultation. The independent directors will report at the Company's 2025 Annual Shareholders' Meeting. The voting results were: 9 votes in favor, 0 votes against, 0 abstentions, and 0 avoidance votes. The proposal was approved with 100% of the votes from attending directors.